Published in Hepatitis Weekly, July 15th, 1996
Previous studies have shown a potential application of antisense oligonucleotides in the treatment of viral infections. Investigators have shown that antisense oligonucleotides can be administered to hepatitis B virus (HBV) infected cells to block virus production in a preexisting infection. In addition, researcher Koichi Nakazono and colleagues have shown that antisense oligo DNA can be targeted to HBV infected hepatocytes in vitro, resulting in specific inhibition...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.